Renieramycin J, a highly cytotoxic tetrahydroisoquinoline alkaloid, from a marine sponge Neopetrosia sp.

Journal of Natural Products

Volumn 66, Issue 8, 2003, Pages 1136-1139

  Oku, Naoya ^a   Matsunaga, Shigeki ^a   Van Soest, Rob W M ^b   Fusetani, Nobuhiro ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIN; RENIERAMYCIN J; TETRAHYDROISOQUINOLINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; DRUG CYTOTOXICITY; DRUG ISOLATION; DRUG POTENCY; DRUG STRUCTURE; HUMAN; HUMAN CELL; NEOPETROSIA; NONHUMAN; NUCLEAR OVERHAUSER EFFECT; PROTEIN SYNTHESIS INHIBITION; PROTON NUCLEAR MAGNETIC RESONANCE; RAT; RNA SYNTHESIS; SPONGE (PORIFERA); STEREOCHEMISTRY; STRUCTURE ANALYSIS;

ALKALOIDS; ANIMALS; ANTINEOPLASTIC AGENTS; DRUG SCREENING ASSAYS, ANTITUMOR; FIBROBLASTS; INHIBITORY CONCENTRATION 50; JAPAN; MOLECULAR STRUCTURE; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PORIFERA; RATS; TETRAHYDROISOQUINOLINES;

ANIMALIA; PORIFERA;

EID: 0041921146     PISSN: 01633864     EISSN: None     Source Type: Journal    
DOI: 10.1021/np030092g     Document Type: Article

References (26)

1. Bioactive Marine Metabolites. Part 120. Part 119: Oku, N.; Matsunaga, S. ; Fusetani, N. J. Am. Chem. Soc. 2003, 125, 2044-2045.
2. Scott, J. D.; Williams, R. D. Chem. Rev. 2002, 102, 1669-1730.
3. Aune, G. J.; Furuta, T.; Pommier, Y. Anti-Cancer Drugs 2002, 13, 545-555.
4. Frincke, J. M.; Faulkner, D. J. J. Am. Chem. Soc. 1982, 104, 265-269.
5. He, H.-Y.; Faulkner, D. J. J. Org. Chem. 1989, 54, 5822-5824.
6. Davidson, B. S. Tetrahedron Lett. 1992, 33, 3721-3724.
7. Parameswaran, P. S.; Nalik, C. G.; Kamat, S. Y. Ind. J. Chem. 1998, 38B, 1258-1263. For the correction of the structure of renieramycin H, see: Saito, N.; Sakai, H.; Suwanborirux, K.; Pummangura, S.; Kubo, A. Heterocycles 2001, 55, 21-28.
8. Parameswaran, P. S.; Nalik, C. G.; Kamat, S. Y. Ind. J. Chem. 1998, 38B, 1258-1263. For the correction of the structure of renieramycin H, see: Saito, N.; Sakai, H.; Suwanborirux, K.; Pummangura, S.; Kubo, A. Heterocycles 2001, 55, 21-28.
9. Fontana, A.; Cavaliere P.; Wahidulla, S.; Naik, C. G.; Cimino, G. Tetrahedron, 2000, 56, 7305-7308.
10. Pettit, G.; Knight, J. C.; Collins, J. C.; Herald, D. L.; Pettit, R. K.; Boyd, M. R.; Young, V. G. J. Nat. Prod. 2000, 63, 793-798.
11. Wright, A. E.; Forleo, D. A.; Gunawardana, G. P.; Gunasekera, S. P.; Koehn, F. E.; McConnell, O. J. J. Org. Chem. 1990, 55, 4508-4512.
12. Rinehart, K. L.; Holt, T. G.; Fregeau, N. L.; Stroh, J. G.; Keifer, P. A.; Sun, F.; Li, L. H.; Martin, D. G. J. Org. Chem. 1990, 55, 4512-4515.
13. Sakai, R.; Rinehart, K. L.; Guan, Y.; Wang, A. H.-J. Proc. Natl. Acad. Sci. U.S.A. 1992, 89, 11456-11460.
14. Sakai, R.; Jares-Erijman, E. A.; Manzanares, I.; Silva Elipe, M. V.; Rinehart, K. L. J. Am. Chem. Soc. 1996, 118, 9017-9023.
15. Suwanborirux, K.; Charupant, K.; Amnuoypol, S.; Pummangura, S.; Kubo, A. ; Saito, N. J. Nat. Prod. 2002, 65, 935-937.
16. Interpretation of the NMR data was conducted with a sample containing ca. 30% of the oxidation product 2.
17. Cooper, R.; Unger, S. J. Antibiot. 1985, 38, 24-30.
18. Trowitzsch-Kienast, W.; Irschik, H.; Reichenbach, H.; Wray, V.; Hofle, G. Liebig Ann. Chem. 1988, 475-481.
19. Saito, N.; Harada, S.; Nishida, M.; Inoue, I.; Kubo, A. Chem. Pharm. Bull. 1995, 43, 777-782.
20. 3): δ 4.33 d (J = 0.5 Hz, H-14); 62.1 (C-14).
21. Lown, J. W.; Joshua, A. V.; Chen, H.-H. Can. J. Chem. 1981, 59, 2945-2952.
22. Ohtani, I.; Kusumi, T.; Kashman, Y.; Kakisawa, H. J. Am. Chem. Soc. 1991, 113, 4092-4096.
23. Kishi, K.; Yazawa, K.; Takahashi, K.; Mikami, Y.; Arai, T. J. Antibiot. 1984, 37, 847-852.
24. Martinez, E. J.; Corey, E. J. Org. Lett. 1999, 1, 75-77.
25. Meyers, A. G.; Plowright, A. T. J. Am. Chem. Soc. 2001, 123, 5114-5115.
26. Oku, N.; Matsunaga, S.; Wada, S.; Watabe, S.; Fusetani, N. J. Nat. Prod. 2000, 63, 205-209.